Document is current
Any future updates will be listed below
-
Authors
Salerno, Simona
Ståhlberg, Anders
Holdfeldt, André
Bexe Lindskog, Elinor
Landberg, Göran https://orcid.org/0000-0001-9004-9403
-
Funding
Funding for this research was provided by:
University of Gothenburg
- License Information
-
More Information
Article History
Received: 6 December 2021
Accepted: 2 May 2022
First Online: 13 May 2022
Declarations
:
: Informed consent was obtained from all patients and the study was approved by the regional ethical review board in Gothenburg (DNR 118-15).
: Not applicable.
: SS, AH and EBL declare no potential conflict of interests. GL and AS are board members and shareholders of Iscaff Pharma AB. AS is a board member and shareholder of SiMSen Diagnostics and Tulebovaasta. The patient-derived scaffold approach and data are patent pending.
